Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Avangard Bank recommended dividends

8/16/24 AVAN

Slavneft reported for 6 months of 2024 by IFRS

8/16/24 SLAV

HeadHunter may pay dividends by the end of 2024

8/16/24 HEAD

Board of Directors of TNS power Rostov-on-Don recommended dividends

8/16/24 RTSB

Board of Directors of TNS energy Voronezh recommended dividends

8/16/24 VRSB

Inter RAO acquired NPO Elsib

8/16/24 IRAO

Yandex began to develop an analog of the Miro platform

8/16/24 YDEX

Detsky Mir will continue to trade through October 14

8/16/24 DSKY

Astrakhanenergosbyt reported for 6 months of 2024 by IFRS

8/16/24 ASSB

Moscow Exchange added 14 more shares to over-the-counter trading

8/16/24 MOEX